Obizur (factor VIII) is a clotting factor replacement that's infused through the veins to treat bleeding episodes in adults with an autoimmune blood condition called acquired hemophilia A. It's typically given at a hospital that's designated as a hemophilia treatment center. How long your treatment is depends on things like your health status and how serious your bleed is. Obizur (factor VIII) doesn't treat the inherited form of this blood condition (congenital hemophilia A) like other similar medications do. Obizur (factor VIII) doesn't have many known side effects.
Obizur (factor VIII) is a coagulation (clotting) factor replacement for adults with acquired hemophilia A who have problems with their clotting factor VIII (FVIII). Clotting factors are proteins in the blood that help control bleeding.
Obizur (factor VIII) works by temporarily replacing factor FVIII in the blood. As a result, the medication helps control bleeds in people who have low levels of functioning factor VIII that's naturally found in the blood.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
See Risks and Warnings.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Obizur (factor VIII) is made in a laboratory using recombinant technology. This process involves making clotting factor VIII in a specific type of genetically-engineered hamster cell. Obizur (factor VIII) isn't made from human blood, so it can't spread viruses found in human blood to you. But because the manufacturing process involves the use of hamster cells, you might be at risk for allergic reactions to Obizur (factor VIII) if you have an allergy to hamsters.
Your healthcare provider will inject Obizur (factor VIII) into your vein. Your dose and how often you need infusions of the medication will depend on things like your weight, how serious your bleed is, and how you're responding to treatment.
No. Obizur (factor VIII) is approved to control bleeding episodes that require hospitalization. Other factor VIII products like Alphanate can help prevent bleeding episodes from happening in the first place. Your provider will determine which product is best for your condition.
No. Obizur (factor VIII) is typically given at a hospital that's specifically designated as a hemophilia treatment center. In addition, a trained healthcare provider must help prepare the medication and infuse it through your vein. The treatment center and your providers will have resources readily available to check how well Obizur (factor VIII) is working to help control your bleed.
Although Obizur (factor VIII) is FDA-approved for treating acquired hemophilia A (AHA), researchers from a small study have seen some benefit of using the medication off-label to treat the inherited form of this blood condition called congenital hemophilia A. There will need to be more studies done to confirm its use for congenital hemophilia A before the FDA says the medication is safe and works well enough for it. Speak with your provider to learn about the differences between AHA and congenital hemophilia and treatment options available for your hemophilia condition.
Obizur (factor VIII) is FDA-approved to treat bleeding episodes in adults with acquired hemophilia A (AHA), an autoimmune blood problem that happens when the body's immune system mistakenly attacks its own clotting factors (most often factor VIII). On the other hand, congenital hemophilia A is a genetic condition, meaning people can inherit the problem from their parents. Although they both involve clotting factor VIII and can cause bleeding, acquired and congenital hemophilia A can be pretty different. People are often diagnosed with congenital hemophilia A early in life, whereas AHA typically occurs in older adults. In addition, bleeding typically happens in the joints, muscles, and soft tissue for congenital hemophilia A, while bleeding in the joints isn't common for AHA.
Obizur (factor VIII) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Rarely, Obizur (factor VIII) can cause allergic reactions, which can be serious. Sometimes, these reactions can lead to life-threatening situations like anaphylaxis, which can include the closing of the throat. Get medical help right away if you experience chest tightness, shortness of breath, wheezing, swelling, or rash.
There's a chance that Obizur (factor VIII) can stop working well for you even though it worked well when you first started treatment. In a clinical study, nearly 1 out of 4 (26%) people who were treated with Obizur (factor VIII) developed inhibitory antibodies to the medication. These antibodies are proteins that can attach to the medication and make it work less well.
Your provider will keep track of how well Obizur (factor VIII) seems to be working for you during treatment. If you seem to stop responding to the medication, your provider might suspect that you've developed antibodies against the medication and might treat your bleeding another way.
This medication is given as an infusion through the veins (intravenously or IV). It must be given by a healthcare provider in a hospital or emergency care setting that's designated as a hemophilia treatment center.
Your provider will calculate your starting dose based on your body weight; the typical starting dose is 200 units/kg of weight.
Any following doses of Obizur (factor VIII) are given every 4 to 12 hours. How often the medication is given depends on how serious your bleed is, your response to the medication, and the FVIII levels in your blood (to make sure they're reaching a particular range that's safe for you).
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Obizur (factor VIII) will not be safe for you to take.
To treat active bleeds or to prevent bleeding episodes during surgery in people with the following conditions: